Intuitive Surgical is trading higher today, showing a modest recovery following the significant 5.8% sell-off experienced during yesterday's session. That prior decline was largely driven by investor concerns regarding the company's full-year procedure guidance, which fell short of expectations despite a 19% revenue growth rate in the most recent quarter. While the company recently announced a collaboration with Deion Sanders to boost patient awareness and is expanding its manufacturing footprint in the Asia Pacific region, there is no specific company-level catalyst from the last 24 hours driving today's move. The stock remains roughly flat in after-hours trading as it stabilizes following the recent volatility.
That explains the day. Whether ISRG is a business worth owning is a longer question. Koyfin has the ten-year financials, margin history and valuation to answer it — 20% off for WhyTheMove readers.
No significant catalyst events detected.
ISRG moved for a reason you can read above. What the company earns, owns and guides to is a separate record. Koyfin is where the question moves from today's move to the business behind it — analyst estimates, filings and earnings transcripts.
Research ISRG in Koyfin →7-day full-access trial · 20% off paid plans